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Crosstalk between malignant and neighboring cells contributes to tumor growth. In East Asia, infection with the liver fluke is a
major risk factor for cholangiocarcinoma (CCA). The liver fluke Opisthorchis viverrini secretes a growth factor termed liver fluke
granulin, a homologue of the human progranulin, which contributes significantly to biliary tract fibrosis and morbidity. Here, extra-
cellular vesicle (EV)-mediated transfer of mRNAs from human cholangiocytes to naÝve recipient cells was investigated following
exposure to liver fluke granulin. To minimize the influence of endogenous progranulin, its cognate gene was inactivated using
CRISPR/Cas9-based gene knock-out. Several progranulin-depleted cell lines, termed DhuPGRN-H69, were established. These lines
exhibited >80% reductions in levels of specific transcript and progranulin, both in gene-edited cells and within EVs released by these
cells. Profiles of extracellular vesicle RNAs (evRNA) from DhuPGRN-H69 for CCA-associated characteristics revealed a paucity of
transcripts for estrogen- and Wnt-signaling pathways, peptidase inhibitors and tyrosine phosphatase related to cellular processes
including oncogenic transformation. Several CCA-specific evRNAs including MAPK/AKT pathway members were induced by expo-
sure to liver fluke granulin. By comparison, estrogen, Wnt/PI3K and TGF signaling and other CCA pathway mRNAs were upreg-
ulated in wild type H69 cells exposed to liver fluke granulin. Of these, CCA-associated evRNAs modified the CCA
microenvironment in naÝve cells co-cultured with EVs from DhuPGRN-H69 cells exposed to liver fluke granulin, and induced
translation of MAPK phosphorylation related-protein in naÝve recipient cells in comparison with control recipient cells.
Exosome-mediated crosstalk in response to liver fluke granulin promoted a CCA-specific program through MAPK pathway which,
in turn, established a CCA-conducive disposition.Neoplastic (2020) 22 203–216Keywords: Opisthorchis viverrini, Liver fluke granulin, Extracellular vesicle, Cellular crosstalkIntroduction
Cholangiocarcinoma (CCA) describes malignancy arising from the bil-
iary epithelium. CCA originates in the cholangiocyte, the specialized 2020 The Authors. Published by Elsevier Inc. on behalf of Neoplasia Press, Inc. This
an open access article under the CC BY-NC-ND license (http://creativecommons.org/
enses/by-nc-nd/4.0/).
tps://doi.org/10.1016/j.neo.2020.02.004
204 Liver fluke granulin promotes Neoplasia Vol. 22, No.5, 2020epithelial cell that lines the intrahepatic and extrahepatic bile ducts, except
for the epithelial cells of the gallbladder. Many CCA are adenocarcinomas
[1,2]. Although the causative agent for many cancers remains obscure
including non-liver fluke infection-associated CCA, the principal risk fac-
tor in liver fluke-endemic regions is well established: infection with
Opisthorchis viverrini and related parasites [3–6]. Infection with O. viver-
rini is the principal risk factor for CCA in the Lower Mekong River Basin
countries including Thailand, Lao PDR, Vietnam and Cambodia [5,6]. It
has been estimated that 10% of people chronically infected with liver
flukes will develop CCA [7]. In regions endemic for opisthorchiasis, the
prevalence of CCA can exceed 80 cases per 100,000 residents [8].
Helminth parasites communicate and interact at the host-parasite
interface [9]. Communication is facilitated by metabolic products secreted
from the tegument and excretory tissues, including via exosomes [10,11].
The liver fluke O. viverrini releases proteins and other metabolites [12],
which influence host cells including cholangiocytes in diverse ways [13–
16]. Whereas the full complement of metabolites released by this parasite
remains generally to be investigated for roles of communication and dis-
ease, a secreted protein termed liver fluke granulin (Ov-GRN-1) has been
the focus of increasing investigation. Liver fluke granulin is a paralogue of
human progranulin, which like the progranulin stimulates cell prolifera-
tion and wound healing, and which appears to contribute to the pathogen-
esis of opisthorchiasis [17–21]. We have exploited this link to more deeply
explore the role of liver fluke granulin in pre-malignant lesions of the bile
duct by undertaking programmed CRISPR/Cas9 knockout of its cognate
gene. Deep sequencing of amplicon libraries from genomic DNA of gene-
edited parasites revealed Cas9-catalyzed mutations within the Ov-GRN-1
locus. Gene knockout rapidly depleted levels of Ov-GRN-1 transcripts
and depleted cellular levels of liver fluke granulin. Furthermore, experi-
mental infection of hamsters with the gene-edited liver flukes resulted in
markedly reduced disease even though gene-edited parasites colonized
the biliary tract and developed into the adult developmental stage of the
liver fluke. These findings confirmed a role for liver fluke granulin in vir-
ulence of the hepatobiliary morbidity characteristic of opisthorchiasis [22].
In the present report, extracellular vesicle-mediated transfer of func-
tional mRNAs to naÝve recipient cells from cholangiocytes that had been
exposed to liver fluke granulin was investigated. In response, extracellular
vesicle-mediated crosstalk promoted CCA-specific translational profile(s)
in the recipient cholangiocytes, including via MAPK signaling that, in
turn, established a microenvironment supportive of carcinogenesis.Materials and methods
Cell lines
The cholangiocyte cell line H69 is a SV40-transformed bile duct epithelial
cell line derived from a non-cancerous human liver [23]. H69 cells were
maintained in H69 complete medium; Ham's F12 nutrient mixture
(25 lg/ml adenine, 5 lg/ml insulin, 1 lg/ml epinephrine, 0.62 lg/ml hydro-
cortisone, 1.36 lg/ml T3-T, and 10 ng/ml epidermal growth factor (EGF),
Dulbecco's Modified Eagle Medium [DMEM] (Gibco), DMEM/F-12
(Sigma-Aldrich) media containing 10% fetal bovine serum (FBS) and 1
penicillin/streptomycin (pen/strep), as described [21,24,25]. H69 cells was
maintained in humidified incubator in 5% CO2 in air at 37 C. H69 cells
were Mycoplasma-free as established using the Lookout Mycoplasma PCR
detection kit (Sigma-Aldrich) and authenticated using short-tandem repeat
profiling (ATCC, Manassas, VA).Lines of progranulin knockout cholangiocytes
To mutate and disrupt the human progranulin gene, huPGRN, with
the aim of minimizing or eliminating endogenous granulin in H69 cellsDownloaded for Anonymous User (n/a) at James Cook University f
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we employed a pre-designed lentiviral CRISPR/Cas9 vector, `All in One
CRISPR/Cas9 vector system (Sigma-Aldrich). Our vector encoded a guide
RNA targeting human progranulin, huPGRN exon 2, which encodes the
granulin-epithelin precursor (GEP); 50-cctgcaatctttaccgtctc-30 on chromo-
some 17: NC_000017.11, region 44,345,086–44-353,106 driven by U6
promoter, and human elongation factor 1a promoter to drive the expres-
sion of a fusion protein comprised of the puromycin N-acetyl transferase
from Streptomyces alboniger (puromycin resistance marker, PuroR) [26],
the Cas9 endonuclease from Streptococcus pyogenes, and green fluorescent
protein (GFP), in that order. The gene cargo of the vector is flanked by
the long tandem repeat (LTRs) of the HIV-1 lentivirus (Fig. 1A).
Competent Escherichiacoli cells were transformed with the plasmid
form of the vector, termed pLV-huPGRNx2, and maintained in LB broth,
100 mg/ml ampicillin. Virions were derived following transfection of
human 293T cells producer cells with pLV-huPGRNx2, using FUGENE
HD transfection reagent (Promega, Madison, WI) and the MISSION™
lentiviral packaging kit (Sigma-Aldrich), as described [27]. Pooled culture
supernatants containing pseudotyped virions were collected at 48–72 h
after transfection of 293T cells, clarified by centrifugation at 500g for
10 min, and passed through a Millipore 0.45 mm pore membrane
(Steriflip-GP, Millipore). Virions were concentrated using Lenti-X con-
centrator (Takara Bio) after which titers were measured by Lenti-X-
GoStix Plus (Takara Bio). For programmed knock-out of huPGRN,
350,000 H69 cells were exposed to 500 ml of pLV-huPGRNx2 virion
(5  105 infectious units [IFU]/ml) in 2.5 ml complete H69 medium
in 6-well plates. One day later, the medium was replaced with medium
supplemented with puromycin at 300 ng/ml for the selection and enrich-
ment of cells carrying the proviral form of the gene-editing virus (survival
of H69 cells in puromycin ranging from 50 to 400 ng/ml was tested at the
outset, aiming to define a concentration to inhibit survival of these cholan-
giocytes. H69 cells were killed by puromycin within 48 h in at 300 ng/ml
puromycin [not shown].) Gene edited cells were maintained in parallel
with H69 cells for 72 h, by which point the control H69 cells had died.
About 5–10% of cells survived, GFP sorted and entered clonal amplifica-
tion. Surviving cells were cultured in complete H69 medium supple-
mented with 300 ng/ml for 20 passages before genotyping. Discrete
three biological replicates were undertaken to establish three puromycin-
resistant huPGRN knock-out cell lines; b1, b2 and b3 (Fig. 2), which
exhibited >70% reductions in levels of huPGRN transcripts and progran-
ulin (Fig. 2A, B). These were termed DhuPGRN-H69 cell lines.Programmed mutation
Following lentiviral transduction and maintenance in 300 ng/ml puro-
mycin, surviving cells were expanded through successive passages. After
passage 20, genomic DNAs were extracted from pools of the enriched,
puromycin resistant DhuPGRN-H69 cells using DNAzol (Molecular
Research Center). We amplified the targeted region of exon 2, huPGRN
using the NGS primer pair; forward primer 50-GACAAATGGCCCACAA
CACT-30 and reverse primer 50-GCATAAATGCAGACCTAAGCCC-30
(Fig. 1B) flanking expected double strand break (DSB) by CRISPR/
Cas9 system. The DNA samples were processed for next generation
sequencing (NGS) using the Ion Torrent Personal Genome Machine
(ThermoFisher), in order to investigate on-target INDELs. The sequenc-
ing libraries were prepared from 10 ng DNA using the Ion Torrent Ampli-
seq kit 2.0-96 LV (ThermoFisher), following the manufacturer's
instructions. The DNA was bar-coded using the Ion Xpress Barcode
Adapters kit and quantified by quantitative PCR using the Ion Library
TaqMan Quantitation Kit (ThermoFisher) after purification of libraries
by Agencourt AMPure XP beads (Beckman). Emulsion PCR was per-
formed using the Ion PGM Hi-Q View OT2 Kit and the Ion OneTouchrom ClinicalKey.com.au by Elsevier on March 26, 2021.















































Fig. 1. Programmed CRISPR/Cas9 mutation of the human progranulin gene. Panel A, linear map of a pre-designed lentiviral CRISPR/Cas9 vector
containing fused codon-optimized puromycin resistance marker (dark gray bar)-Cas9 (yellow bar) and green fluorescent protein (green bar) driven by the
mammalian elongation factor alpha-1 promoter (dark blue arrow); guide RNA (gRNA) targeting human granulin exon 2 (red bar) is expressed from a
single vector. The human U6 promoter (blue arrow) drove the gRNA. The vector backbone includes the 50- and 30-long terminal repeats (LTR) of the
HIV-1 provirus (light gray blocks). Panel B, schematic representation of the partial human granulin gene precursor, huPGRN on chromosome 17:
NC_000017.11 regions 44,345,086–44,353,106 (8021 bp) and protein structure. Nucleotide sequence in exon 2 encodes the N-terminus and part of
the granulin/epithelin module (GEM) of progranulin; indicating locations of gRNA (4417–4438 nt; red colored-letter) predicted double-stranded break
(DSB) (red arrow). Panels C–E, on target INDEL mutations in DPGRN-H69 analysis by NGS libraries and CRISPResso bioinformatic platform.
Frequency distribution of position-dependent insertions (red bars) (C) and deletion (magenta) (D) the major INDELs; 6 and 2 bp deletions at the
programmed CRISPR/Cas9 cleavage site. Other minor mutations including 1 bp insertion (red square) or base substitution (bold) were observed further
(>10 bp) predicted cleavage site (E).
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Fig. 2. Reduction of progranulin transcript and protein expression levels and cell proliferative effects of liver fluke granulin. Panels A and B, reduction of
huPGRN transcription levels from DhuPGRN-H69 cell; red bar (70%) comparing with H69 reference (black bar). The huPGRN differential
transcript after normalization with human GAPDH gene; mean þ SD, n = 3 (biological replicates); P < 0.0001 (****), unpaired t-test. Diminished level of
huPGRN revealed by WB analysis using anti-PGRN antibody (64 kDa) compared with anti-GAPDH antibody (36 kDa). Progranulin levels in
DhuPGRN-H69 cells (red bars) was reduced by 80%. The GAPDH levels were stable within three biological replicates. These decreased levels of
progranulin were significantly different from H69 (black bars); n = 3 (biological replicates); P < 0.0001 (****), unpaired t-test. Panel C, real time
monitoring of H69 vs DhuGRN-H69 cell proliferation before and after addition of liver fluke granulin. The lower normalized cell index (nCI) of
DhuGRN-H69 cells (discontinuous red lines) compared with H69 cells (discontinuous gray lines) were monitored over 48 h. The nCI of DhuGRN-H69
cells was recovered as in H69 cells nCI value after addition of liver fluke granulin at 100 nM for 24 h, and higher than H69 from 24 to 48 h. The nCI
signals are shown as mean þ SD, for 3 independent experiments, and assessed using two-way ANOVA with Dunnet's multiple correction. Comparing
100 nM liver fluke granulin treatments on each cell type to untreated cells (either H69 vs 100 nM liver fluke granulin treated H69 or DhuPGRN-H69 vs
100 nM liver fluke granulin -treated DhuPGRN-H69): P < 0.05 (*); P < 0.01 (**); P < 0.001 (***). Comparing 100 nM liver fluke granulin-treated H69
to 100 nM liver fluke granulin-treated DhuPGRN-H69: P < 0.05 (#); P < 0.001 (###).
206 Liver fluke granulin promotes Neoplasia Vol. 22, No.5, 20202 system (ThermoFisher). Template-positive ion sphere particles (ISPs)
were enriched using the Ion Torrent OneTouchES. Enriched ISPs were
loaded on a PGM 314R v2 chip and sequenced using the Ion PGM
Hi-Q View Sequencing Reagents (ThermoFisher). Raw sequencing data
were processed using the Torrent Suite software v5.0 (ThermoFisher),
as well as the coverage analysis and variant caller (VC) v5.0 plugins. Pro-
cessed reads were aligned to the human reference genome (hg38) [28].
The identified variants and the depth of coverage were visually confirmed
by the Integrative Genomic viewer (IGV, Broad Institute, MIT, Cam-
bridge, MA). Nine percent of reads were filtered out by post processing.
The filtered sequences, average read length 176 bp, were converted to fastq
format and analyzed for non-homologous end joining (NHEJ)-mediated
mutations using the CRISPResso pipeline [29,30]. Sequence reads were
compared to the reference PCR sequence of the wild type huPGRN gene,
GenBank M75161.1 (Fig. 1C–E).
Cellular proliferation
Proliferation of H69 and DhuPGRN-H69 cells in response to exposure
to 100 nM recombinant liver fluke granulin [17,21] was quantified using
the impedance-based xCELLigence real time cell analysis (RTCA)
approach (ACEA Biosciences). The liver fluke granulin peptide
(10 kDa) was concentrated using Centripep with cut-off 3 kDa (Eppen-
dorf) and resuspended in low salt solution, Opti-MEM. The absorbance at
205 nm and concentration of liver fluke granulin was determined by using
a Nanodrop 2000c spectrophotometer (ThermoFisher) [31]. Five thou-
sand cells/well were seeded in 16-well E-plates (ACEA) in H69 complete
media. E-plates was inserted in the xCELLigence DP platform at 37 C,
5% CO2 and changes in impedance reflecting cell adhesion and prolifer-
ation record at intervals of 20 min for 24 h. On the following day, theDownloaded for Anonymous User (n/a) at James Cook University f
For personal use only. No other uses without permission. Comedium was removed and replaced with H69 complete medium supple-
mented with liver fluke granulin at 100 nM. Cellular proliferation was
monitored for 48 h for the wild type H69, liver fluke granulin-treated
H69, and DhuPGRN-H69 cells with and without liver fluke granulin
treatment, and displayed here as change of impedance (Cell Index) after
normalizing to the signals for the wild type H69, assigned as the reference
cell line (RTCA Software 1.2, ACEA) [32].
Isolation and characterization of extracellular vesicles
The H69 or DhuPGRN-H69 cells were treated with 100 nM liver
fluke granulin in H69 complete media with 10% exosome depleted-
FBS. Forty-eight hours later, were harvested the supernatant from cell cul-
ture of H69 with or without, and DhuPGRN-H69 with or without liver
fluke granulin. The supernatants were collected at 48 h following addition
of liver fluke granulin and cellular debris pelleted and removed by centrifu-
gation 2000g, 15 min. The supernatant was filtered through a 0.22 lm
pore size membrane (Millipore, Billerica, MA), mixed with 0.5 volume of
tissue culture total exosome isolation reagent (Invitrogen, catalog no.
4478359), and incubated for 16 h at 4 C. Thereafter, the EV pellet (iso-
lated by centrifugation at 10,000g, 4 C, 60 min) was re-suspended in
1 PBS [33]. EVs were investigated in co-culture assays and the EV-
associated RNA (evRNA) and protein (evProtein) of the EVs were inves-
tigated following extraction of exosomal contents using the Total Exosome
RNA and Protein Isolation kit (ThermoFisher).
The identification of protein markers on the isolated EVs was under-
taken using the commercially available Exo-Check Exosome Antibody
Array kit (System Biosciences): the array included 12 pre-printed spots
and was used with the cognate antibodies specific for the exosome markers
CD63, CD81, ALIX, FLOT1, ICAM1, EpCam, ANXA5 and TSG101.rom ClinicalKey.com.au by Elsevier on March 26, 2021.
pyright ©2021. Elsevier Inc. All rights reserved.
Neoplasia Vol. 22, No.5, 2020 Liver fluke granulin promotes 207The array included the following controls: a GM130 cis-Golgi marker to
monitor cellular contamination, a positive control spot derived from
human serum EVs, and a blank spot as a background control. The mem-
brane was developed with SuperSignal West Femto Maximum Sensitivity
Substrate (ThermoFisher Scientific) and visualized and quantified on the
ChemiDoc Imager (Bio-Rad) [34]. The intensity of EV protein markers
was read (gray scale) (ChemiDoc), and subtracted with negative back-
ground intensity. The signal intensity for each protein was plotted and
compared (Fig. 3B). The evProtein was also confirmed for EV marker
expression by western blot analysis against anti-CD9 and CD81 (Abcam).
Briefly, 10 mg of the evProtein was separated on gradient (4–12%) SDS-
PAGE gel and transferred to nitrocellulose membrane (Bio-Rad). After
blocking with 5% skim milk in Tris-buffered saline (TBS)-Tween for
60 min, the membrane was incubated with specific antibody against
CD9 or CD81, followed (after washing) by anti-rabbit HRP-linked sec-
ondary antibody (DAKO Corporation catalog no. P0448) diluted 1 in
2000. Signals from ECL substrate were detected by chemiluminescence
(Amersham Bioscience) and captured and analyzed (ChemiDoc, Bio-
Rad) (Fig. 3C).
For immunofluorescence staining of EV-like particles from H69 cells
were proceeded by culturing the cells in glass slide chamber overnight
before fixed at 4 C in ice-cold methanol for 10 min, washed 3 times in
1 PBS, and permeabilized in 0.1% Triton X-100/PBS for 10 min at
room temperature. Nonspecific binding was blocked with 0.5% Tween-
20/PBS containing 1% bovine serum albumin (BSA) for 30 min. The pri-
mary antibodies against CD81 labeling with fluoroflore-488 was incu-
bated for 60 min at room temperature. The incubated cells were washed
3 times in 1 PBS. Before visualization by confocal microscope, we
stained the cell nucleus with DAPI. The EVs were observed and particle
sized were measures in H69 cytoplasm (Fig. 3A)Quantitative real time PCR
Total RNA and evRNA either from H69 or DhuPGRN-H69 cells
were isolated using RNAzol (Molecular Research Center, Inc.) or total
exosome RNA isolation kit (ThermoFisher) following the manufacturer's
instructions. One microgram of RNA was treated for DNase, then used
for reverse transcription by an iScript cDNA synthesis kit (Thermo Fisher
Scientific). Real time PCR was performed in ABI7300 Real time PCR
machine using the SsoAdvanced Universal SYBR Green Supermix (Bio-
Rad). The PCR reaction consisted of 5 ml SsoAdvance SYBR Green
PCR master mix, 0.5 ml of 10 mM forward and reverse primers, and
2 ml of 5 times diluted template cDNA in a total volume of 10 ml. The
thermal cycle was initiation cycle at 95 C for 30 s followed by 40 cycles
of annealing at 55 C for 1 min. Samples were analyzed in at least 3 bio-
logical replicates (various cell passages) and in typical reactions. The
human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) transcript
was run parallel with human granulin (huPGRN) and used for gene nor-
malization. The differential granulin transcript fold change was calculated
by formula 2ddCt [35]. The specific primers for huPGRN and GAPDH
are as follows: PGRN-F: 50-atgataaccagacctgctgcc-30, PGRN-R: 50-aaa
cacttggtacccctgcg-30, GAPDH-F; 50-tgtagttgaggtcaatgaaggg-30 and
GAPDH-F 50-tgtagttgaggtcaatgaaggg-30. The fold change was obtained
by comparing treated-samples with the untreated control (indicated as a
value of 1, 100%). The means and standard deviations of differential tran-
script expression were calculated by independent Student's t-tests using
Prism version 8 software (GraphPad).Western blot and densitometry
Protein lysates and protein extracted from EVs (evProtein) from H69
and DhuPGRN-H69 cells were prepared using M-PER mammalian pro-Downloaded for Anonymous User (n/a) at James Cook Univ
For personal use only. No other uses without permisstein extraction reagent (ThermoFisher) and exosome protein isolation
kit (ThermoFisher), respectively, following the manufacturer's protocols.
Protein concentrations were determined using the Bradford assay [36].
Ten micrograms of cell lysate or 20 mg of evProtein was separated on gra-
dient SDS-polyacrylamide gel (4–12% Bis-Tris, Invitrogen) and trans-
ferred to nitrocellulose membrane (Trans-Blot Turbo system, Bio-Rad).
Signals were identified with a chemiluminescence substrate (GE Health-
care) following probing with antibodies specific for progranulin (Abcam)
or GAPDH (Sigma-Aldrich), and with HRP conjugated-secondary anti-
bodies. Expression levels of huPGRN were imaged using the FluroChem
system (Bio-techne) and relative expression levels of progranulin investi-
gated after GAPDH level normalization. Signals were compared using
independent Student's t-tests.Cholangiocarcinoma (CCA) gene expression panel
A predesigned Cholangiocarcinoma PrimePCR™ Array Pathway Panel
(88 targets) (Bio-Rad) was used to investigate the CCA gene expression
profile of transcripts in the cargo of EVs released by H69 cells exposed
to liver fluke granulin. One microgram of total RNA from EV samples
was converted to cDNA (Supermix iScript kit, Bio-Rad). A one in 10 dilu-
tion of cDNA was used for qPCRs with a final concentration of 1
SsoAdvanced universal SYBR super mix (Bio-Rad) and 1PrimePCR
assays for the designated target. Reactions were performed (three technical
replicates) at 10 ll final volume, using the iQ5 real time PCR system (Bio-
Rad) starting with activation at 95 C for 2 min, followed by 40 cycles of
denaturation at 95 C, 5 s, and annealing/elongation at 60 C, 30 s.
Specificity of target amplification was confirmed by melting-curve analysis.
Controls for evaluating reverse transcription, RNA quality, genomic DNA
contamination and kit performance were included on the array (Bio-Rad).
The reference genes GAPDH, HPRT1 and TBP were assayed for relative
gene expression to normalize for variation in quantity of input mRNA.
The DNA template served as a positive real-time PCR control for the cor-
responding gene assay. PrimePCR™ Analysis Software (Bio-Rad) was used
for analysis of differential fold changes of target genes. Transcript readings
higher than 2-fold change were read as positive signals.Uptake of PKH26-labeled EVs by cholangiocytes
To investigate whether liver fluke granulin-treated H69 communicated
CCA-conducive mRNAs to adjacent naÝve cells using exosomal cargo,
EVs were labeled with PKH26 Fluorescent cell linker kit (Sigma-
Aldrich) [37,38]. In brief, EVs (equally 6.25 lg evProtein) isolated from
culture media were re-suspended in one ml of diluent C, to maintain cell
viability with maximum dye solubility and staining efficiency [39] and
labeled by addition of PKH26 to 2 lM final concentration. The samples
were incubated for 5 min with gentle, periodic mixing, after which 2 ml of
1% BSA was added to bind excess dye. The mixture containing PKH26-
labeled EVs was diluted into tissue culture exosome isolation reagent
(ThermoFisher), as above, after which the EVs were re-suspended in
H69 complete medium and co-cultured with H69 or DhuPGRN-H69
cells at 80–90% confluence in wells of poly-L-lysine-coated microscope
slide chambers (Lab-Tek II). A negative control group was co-cultured
with EVs not stained with PKH26. After incubation with EVs for
90 min at 37 C in 5% CO2, the cells were stained with NucBlue Live
Cell Stain ReadyProbes (Invitrogen) and visualized on a Cell Observer
SD Spinning Disk Confocal Microscope (Zeiss). A negative control for
inhibition of endocytosis was included, which involved addition of Pitstop
2, an inhibitor of clathrin-mediated endocytosis (Abcam) at 30 lM to
recipient cells for 15 min [40], before co-culture with labeled-EVs
(Fig. 4A–C).ersity from ClinicalKey.com.au by Elsevier on March 26, 2021.
ion. Copyright ©2021. Elsevier Inc. All rights reserved.
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To investigate whether CCA-associated functional RNAs in EVs were
translated by naÝve H69 cells (both wild type and the DhuPGRN), theDownloaded for Anonymous User (n/a) at James Cook University f
For personal use only. No other uses without permission. Cocells were incubated with the EVs as described above. For this, 5  104
cells were seeded into a well of 24-well plate and maintained overnight
in H69 complete medium [41]. Thereafter, EV particles were dispensed
into each well and cultured for 24 h. The cells were harvested with cellrom ClinicalKey.com.au by Elsevier on March 26, 2021.
pyright ©2021. Elsevier Inc. All rights reserved.
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Neoplasia Vol. 22, No.5, 2020 Liver fluke granulin promotes 209scraper, washed 3 times with 1 PBS, and thereafter resuspended in lysis
buffer provided in the Human MAPK Phosphorylation kit). The protein
concentration of the cell lysate was determined by the Bradford method
(Bio-Rad) before proceeding to probe the human MAPK phosphorylation
array, catalog no. ab211061 (Abcam), following the manufacturer's
instructions. In brief, the protein sample was incubated with each array
overnight at 4 C with gentle orbital shaking. Unbound proteins were
removed, and the arrays washed three times with wash buffer. Arrays were
incubated with the horseradish peroxidase conjugated anti-rabbit IgG anti-
body for 120 min at room temperature. Thereafter, the array membranes
were washed three times with wash buffer prior to incubation with freshly
prepared detection solution for two min at room temperature. Protein sig-
nals were visualized using the ChemiDoc system (Bio-Rad). The intensity
score of each duplicated array spot was ascertained, and normalized array
data were calculated according to the manufacturer's recommendation. To
normalize array data, one array was defined arbitrarily as the reference, to
which the other arrays were compared. The following algorithm was used
to calculate and determine the signal expression between like analyses as
previously described [42,43]:
X(Ny) = X(y)*P1/P(y), where P1 = mean signal density of positive con-
trol spots on reference array; P(y) = mean signal density of positive control
spots on array `y'; X(y) = mean signal density of spot `X' on array for sam-
ple `y'; and X(Ny) = normalized signal intensity for spot `X' on Array `y'.
We used EVs-derived-DhuPGRN-H69 cells (not exposed to liver fluke
granulin) as the control to contrast with the in vivo translation of CCA-
associated mRNAs in the treatment groups.
Biological and technical replicates, statistics
Biological replicates represented parallel measurements of biologically
discrete samples in order to capture random biological variation. Technical
replicates were undertaken as well; these represented repeated measure-
ments of the same sample undertaken as independent measurements of
the random noise associated with the investigator, equipment or protocol.
Responses of knockout versus wild type H69 cell line genotypes including
before and after exposure to liver fluke granulin were compared using
2way ANOVA, including Dunnet's correction for multiple comparisons
at successive time points. Thereafter, Tukey's honest significance and Stu-
dent's t tests were performed to compare treatment groups. Cell index (CI)Fig. 3. EV-derived H69 cell characterization and PGRN expression. Panel
fluorophore 488-labeled anti-CD81 antibody (green dot, panel A) around DA
ranged from 55 to 80 nm. The protein composition of EVs were determined u
spots indicate presence of the target protein (upper panel). Absence of a spot fo
gray scale was also plotted (lower panel). Panel C, WB analysis for the exosom
Panels D and E, both the evRNA and evProtein from DhuPGRN-H69 show
normalization with GAPDH in comparison to H69 [black bar] (red bar, pan
P < 0.0001 (****), n = 3. Panels F–H, show an induction of CCA-related m
granulin. The heat map was plotted based on the differential transcript fold c
reference from H69 with liver fluke granulin treatment (panel F) and DhuPGR
quantities of evRNAs from each group were probed individually with 88 C
ANOVA gene profiles (55 from 88 transcripts were detected) in DhuPGRN-H
PTPN13, SERPINA3, SERRPINE2 and SOX11 (panel H). However, most o
of DhuPGRN-H69 (panels G and H). The CCA mRNA profiles after liver flu
markedly dissimilar following exposure to liver fluke granulin with P < 0.00
evRNAs after exposure to liver fluke granulin in DhuPGRN-H69 compared
statistical significance was calculated from differential fold changes in transc
showed 1–15 folds (gradient red bar) level of induction of transcription. Th
absence of expression (gradient blue bar). The transcripts from non- or treate
black bar and gray-cross bar, respectively. The heat map was plotted from th
Downloaded for Anonymous User (n/a) at James Cook Univ
For personal use only. No other uses without permissassays were performed in triplicate. CI was automatically registered by the
RTCA software (ACEA Biosciences Inc., San Diego, CA). Means þ SD
indicates plotted using GraphPad Prism 8 (GraphPad Software, San
Diego, CA). Values of P < 0.05 were considered to be statistically
significant.
Supplementary Fig. 1 provides a schematic overview of experimental
design and methods.Database accessions
Nucleotide sequence reads reported here have been assigned SRA
accessions SRR9735031-34 at GenBank, NCBI, and the study has been
assigned BioProject ID PRJNA556235 and BioSample accession
SAMN12344265.Results
Progranulin mutation in cholangiocytes by CRISPR knockout
The progranulin gene, huPGRN, in the human H69 cholangiocyte cell
line was targeted for CRISPR/Cas9-mediated programmed mutation. The
programmed target site encodes the N-terminus and part of the granulin/
epithelin module of human PGRN (Fig. 1A, B). Wild type H69 cells were
transduced with pLV-huPGRNx2 virions at >5  105 infective units
(IFU)/ml and, a day later, culture medium supplemented with puromycin
at 300 ng/ml added to the virion-transduced cells with the goal of enrich-
ment of transgenic cells exhibiting puromycin resistance [26]. Three
daughter cell lines, termed DhuPGRN-H69 lines, b1, b2 and b3, exhib-
ited >70% reduction in levels of huPGRN transcripts and of protein as
assessed by RT-PCR and western blot (WB), respectively (Fig. 2A, B).
Thereafter, discrete amplicon libraries were constructed from each of the
three daughter cell lines, from which 139,362, 107,683, and 179,122
sequence reads were obtained. The reads were analyzed using the CRIS-
PResso pipeline to monitor programmed gene mutations and subsequent
non-homologous end joining (NHEJ) mediated-repair and insertion-
deletion (INDEL) profiles (Fig. 1C, D) [29]. This analysis revealed muta-
tions in 32.3, 41.9 and 44.3% of the alleles in the lines, respectively. Sim-
ilar INDEL profiles were seen among the three libraries: single nucleotideA, the visualization of EVs from H69 cells by in situ hybridization using
PI-stained cell nuclei (blue color). The H69-derived EV-like particle sizes
sing the Exosome Antibody Array (SBI System Biosciences). Panel B, dark
r GM130 confirmed the absence of cellular contaminants. The intensity in
e-specific markers; strongly positive signal for CD9 and CD81 were found.
ed reduction of 90% differential transcript levels [red bar, panel D] after
el D). The levels of progranulin were reduced by 90%; unpaired t-test,
RNAs carrying cholangiocyte derived-EVs after exposure to liver fluke
hange as determined using the CCA-related gene Array using H69 as the
N-H69, DhuPGRN-with liver fluke granulin treatment (panel H). Similar
CA targets in triplicate; there were slight differences (P < 0.05 by 2way
69 vs H69 (panel A) by absent of DPYD, ESR, KDM3A, LEF1, PRKC9,
f these genes were recovered after exogenous liver fluke granulin treatment
ke granulin treatment of EVs derived from DhuPGRN-H69 and H69 were
01, 2way ANOVA (panels F and G). Panel G, shows the CCA-related
with its mRNA profile (P < 0.0001 with two-tailed, paired t-test). The
ription. The liver fluke granulin (rOv-GRN-1) treatment group of cells
e `1' indicates baseline (white bar) level expression, and `0' indicated the
d- rOv-GRN-1treatment were not detected (no baseline signal) indicate in
e average transcript level ran in triplicates using Prism v8.
ersity from ClinicalKey.com.au by Elsevier on March 26, 2021.
ion. Copyright ©2021. Elsevier Inc. All rights reserved.
210 Liver fluke granulin promotes Neoplasia Vol. 22, No.5, 2020insertions, 6 and 2 bp deletions, and also other deletions from one to
10 bp in length were common at the position predicted for the pro-
grammed double stranded chromosomal break (Fig. 1C, E, dashed line).
Fig. 1E presents examples of the mutated alleles. This mutational land-
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granulin
Prolonged reduction in levels of progranulin were observed for >40
passages in three daughter DhuPGRN-H69 lines under puromycin treat-
ment (not shown). By that point, differential huPGRN transcript fold
changes were stably reduced to 30% (29.8 þ 4.7%) in DhuPGRN-
H69 cells compared with levels in the parental, wild type cells (Fig. 2A)
(t-test, P < 0.0001). When examined by WB, the levels of progranulin
in DhuPGRN-H69 cells had fallen to 21.5 þ 2.3% of those in the parental
H69 line cells, normalized against the human GAPDH reference (Fig. 2B)
(t-test, P < 0.0001). A band at the predicted mass of progranulin, 64 kDa,
was evident in each of three biological replicates (Fig. 2B, lanes b1-b3), as
was the GAPDH signal at 36 kDa.
To assess the consequence of loss of huPGRN following the pro-
grammed gene knockout, cellular proliferation and the mitogenic activity
of recombinant liver fluke granulin (rOv-GRN-1) were monitored using
the xCELLigence approach. This label-free cell-based assay system uses
culture plates bearing microelectrodes for non-invasive measurement dur-
ing cell culture (26). The rate of H69 and DhuPGRN cell growth was
monitored for 48 h and differences compared every 8 h. Both the wild
type and the daughter mutant DhuPGRN cholangiocytes proliferated at
a similar rate for 48 h, suggesting that the programmed knockout of
huPGRN was not detrimental to normal cell growth. Next, the wild type
and mutant H69 cell lines were exposed to liver fluke granulin at 100 nM
[45]. Upon addition of liver fluke granulin, the rates of proliferation of
DhuPGRN-H69 and H69 were similar (Fig. 2C, solid lines) over the first
32 h, after which DhuPGRN-H69 cells grew significantly quicker than
H69s (orange solid circles). Liver fluke granulin induced significantly fas-
ter growth from 16 h onwards in both H69 and DhuPGRN H69 cells
compared to control groups (Fig. 2C, dotted lines) not exposed to liver
fluke granulin (two-way ANOVA with Dunnet correction; P < 0.001),
confirming earlier findings with H69 and other cells [17,21].H69 cholangiocytes released extracellular vesicles
Extracellular vesicle (EV)-like particles recovered from culture super-
natants of H69 cells were investigated. Confocal microscopical observation
revealed EV-like particles that were probed with anti-CD81 labeled with
fluorophore 488 (green) surrounding DAPI-stained nuclei (blue) of
H69 cells (Fig. 3A). Dot-blot based biochemical characterization (Exo-
Check Array) revealed the following exosomal markers with intensity (gray
scale) between 10 and 70: flotillin-1 (FLOT-1), intercellular adhesion
molecule 1 (ICAM), ALG-2-interacting protein 1 (ALIX), CD81, epithe-
lial cell adhesion molecule (EpCAM), annexin V (ANXAS) and tumor sus-
ceptibility gene 101 (TSG101), while the positive control showed
intensity >100 (Fig. 3B). The purified EVs were negative for cis-Golgi
matrix protein (GM130) when compared to the blank control sample,
indicating the absence of contaminating cellular debris. WB analysis ofFig. 4. Uptake of extracellular vesicles and paracrine transfer of mRNAs from
micrographs showing uptake of PKH26-labeled EVs into recipient cholangio
red—PKH26-labeled EVs. Pitstop 2 blocked clathrin-dependent endocytos
Magnification, 40; scale bar, 10 mm. Arrows indicate internalized EVs in naÝ
which they were co-cultured with EVs from liver fluke granulin-activated Dhu
(panel D indicates the key of antibody spot in duplicate) on the human MAPK
of the spots was quantified by densitometry analysis (panels E and F) (RFU). R
higher than control groups (grey bars) namely, GSK3a, MKK3, mTOR, p38
these protein revealed statistically significant differences in comparison with i
individual sets per sample.
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markers of EVs [46,47], with chemiluminescent signals on the blot at
24 kDa and 26 kDa, respectively (Fig. 3C). EV particle size distribution
ranged from 55 to 80 nm. These findings confirmed the identity as EVs
of the particles released from the H69 cells as previous studies [48,49].Programmed knockout of huPGRN levels of progranulin in EVs
The programmed mutation induced INDELs at exon 2 of the huPGRN
locus lead to reduced levels of progranulin within the protein complement
of the EVs. Specifically, we determined the expression of huPGRN extra-
cellular vesicle mRNA (evRNA) and progranulin (evProtein) released by
each of three replicate lines of puromycin resistant cells, at passage number
20 in each case. By this point, EVs from DhuPGRN-H69 cells included
7.2 þ 2.6% only of the levels of huPGRN transcripts and 10.5 þ 2.0% pro-
granulin compared to EVs from H69 cells, after normalization with
GAPDH (Fig. 3D, E) (unpaired t-test, P < 0.0001, both for transcription
and protein expression). Expression of progranulin was revealed by WB
with an anti-progranulin antibody (target mass, 64 kDa) compared with
anti-GAPDH antibody (36 kDa). Levels of the GAPDH, the loading con-
trol, were similar both in cell lysates and EV-associated proteins of the par-
ental H69 and daughter DhuPGRN cells (Fig. 3E).CCA-related profiles of transcripts in EVs shed liver fluke granulin-
exposed cholangiocytes
To investigate if liver fluke granulin stimulated H69 cells shed EVs
containing CCA-related transcripts, the huPGRN gene was mutated by
CRISPR/Cas9 knockout (above). As noted, this gene knockout was
undertaken in order to minimize levels of endogenous progranulin. The
EV-exposed DhuPGRN-H69 cells showed similar CCA-related mRNA
base line profiles as seen with the CCA-array panel of 88 targets (Bio-
Rad) probed with the H69 evRNAs. However, 10 evRNAs were not evi-
dent in EVs shed from DhuPGRN-H69 cells following gene knockout:
dihydropyridine dehydrogenase (DPYD), estrogen receptors (ESR) 1
and 2, lysine-specific demethylase 3A (KDM3A), lymphoid enhancer-
binding factor-1 (LEF1), protein tyrosine phosphatase (PRKC9), non-
receptor type 13 (PRIN13, a Fas-associated phosphatase), serpin peptidase
inhibitor, clade A, member 3 (SERRINA3), serpin peptidase inhibitor,
clade E, member 2 (SERRPINE2), and SRY-related HMG-box 11
(SOX11) (Fig. 3H). By contrast, these transcripts were all present in
evRNA of H69 cells. DPYD, ESR1, ESR2, KDM3A and SOX11genes
participate in pyrimidine catabolism, hormone binding, DNA binding
and activation of transcriptions and activate transcription factor, respec-
tively. LEF1encodes a transcription factor that is involved in Wnt signal-
ing. PTPN13 is a member of protein tyrosine phosphatase family, which
regulates a variety of cellular processes including oncogenic transformation
[50]. The PRINA3 and SERPINA3 genes encode inhibitors of proteases
and peptidases. The profiles of evRNA (from three pooled biological repli-donor to naÝve recipient cells. Panels A and B, representative fluorescence
cytes; blue—nuclei staining with the NucBlu Live Cell Stain ReadyProbe,
is of EVs (C). Merged images shown in lower panel with bright field.
ve cells. Panels D to F, cholangiocytes were grown to 80% confluence after
PGRN-H69 cells for 24 h. The cell lysate (500 ng) was used for 17 targets
phosphorylation antibody array; ab211061 (Abcam). The relative density
ed boxes and red bars represent the predominant proteins that significantly
, p53, p70S6K and RSK1. The MAPK phosphorylation protein pattern of
ts control; P < 0.0001, 2way ANOVA. Data represent the average of two
ersity from ClinicalKey.com.au by Elsevier on March 26, 2021.
ion. Copyright ©2021. Elsevier Inc. All rights reserved.
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fluke granulin, seven transcripts were detected based on the array panel,
specifically ESR1, KDM3A, LEF1, PRKC9, PTPN13, SERRPINE2,
and SOX11 (Fig. 3F, H, normalized with H69; Fig. 3G, normalized with
DhuPGRN-H69).Specific CCA pathways impacted by liver fluke granulin
There were 52 and 43 from 88 CCA-related genes expressed from H69
and DhuPGRN-H69 derived-EVs following treatment with liver fluke
granulin, respectively. The transcript profiles H69 and DhuPGRN-H69
derived-EVs were dissimilar (Fig. 3F, H). For evRNA from H69 cells, ele-
vated levels were induced (4.1- to 14.1-fold changes) for genes encoding
the chloride intercellular channel 5 (CLIC5), cannabinoid receptor
(CNR1), chemokine (C-X-C-motif) receptor 4 (CXCR4), epidermal
growth factor receptor (EGF) family (ERBB2), estrogen pathway (ESR1,
ESR2), Frizzled 2-Wnt receptor (FZD7), homeobox A9 (HOXA9), hap-
toglobin (HP), insulin-like growth factor (IGF), insulin-link growth factor
2 mRNA binding protein 3 (IGF2BP3), zinc finger protein (KDM3A),
keratin family (KRT19), transcription factor involved in the Wnt signaling
pathway (LEF1), lipoprotein lipase (LPL), MAP kinase family (MAPK13),
O6-methylguanine-DNA-methyltransferase (MGMT), natriuretic peptide
B (NPPB), phospholipase A2 (PLA2G2A), peptidase inhibitor (SER-
PINA3), SRY-related HMG-box (SOX 2 and SOX11) family involves in
the regulation of embryonic development and in the determination of cell
fate (Fig. 3F, H). By comparison, liver fluke granulin activated-
DhuPGRN-H69 (i.e. without endogenous progranulin) showed elevated
levels of transcripts (4.8- to 9.5-fold change) encoding ATP-binding cas-
sette transporter (ABCC1, ABCC4), serine/threonine protein kinase family
(CAMK2G), ERBB2 enhancing kinase-mediated activation, F-box protein
family (FBXW7), proinflammatory cytokine 17A (IL17A), reductase sub-
unit M1 (RRM1), MAPK13, enzyme responsible for the excision of 8-
oxoguanine, enzymes involved in fatty acid biosynthesis (SCD), protein
tyrosine phosphatase family involved in cell growth differentiation mitotic
cycle and oncogenic transformation (PTPN13), SOX2, SOX1, and zinc
finger protein ZNF827 involved in telomere chromosome remodeling.
Based on these findings, at least two EV-associated transcripts, ERBB2
and MAPK13 were identified as participants of the MAPK signaling path-
way and they exhibited marked fold change (>4) in EVs derived from
DhuPGRN-H69 cells following activation by liver fluke granulin. These
findings concur with a central role hypothesized for the MAPK pathway
in liver fluke infection induced-cholangiocarcinogenesis [21,51].Human progranulin supplements influence of liver fluke granulin on
cholangiocarcinogenesis
Analysis using the CCA PrimePCR Array (Bio-Rad) revealed that 41 of
the 55 CCA-related genes induced transcription by two- to four-fold.
These 41 genes included actin 1 (ACTA1), breast cancer 1 (BRCA1), epi-
dermal growth factor receptor (EGFR), F-box and WD40 repeat domain
containing-7 (FBXW7), MAPK13, mitochondrial ribosomal protein S6
(MRPS6), msh home box 1 (MSX1), metadherin (MTDH), neuron nav-
igator 2 (NAV2), transcription factor (NPAS2), ornithine decarboxylase 1
(ODC1), RRM1, SCD, SERRPINE, TGF-beta signaling family member
(SMAD4), tubulin b2a (TUBB2A), ZNF827. Additional genes with ele-
vated levels of transcripts in evRNA (>4-fold change) were noted above.
Based on these findings, the endogenous growth factor progranulin
appeared to supplement the action of liver fluke granulin in the cholangio-
cyte in establishing a carcinogenesis-conducive transcriptional profile. This
outcome may mimic events during natural infection with O. viverrini
where the liver fluke residues within the bile duct, secretes liver fluke gran-
ulin that is, in turn, taken up by cholangiocytes [17] and, which con-Downloaded for Anonymous User (n/a) at James Cook University f
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manifests in due course [6,21,52].EVs secreted from liver fluke granulin-activated donor cells transfer
CCA-MAPK-related functional mRNAs to naÝve cells
To investigate paracrine communication involving transfer of EV-
associated mRNAs from donor liver fluke granulin treated-DhuPGRN-
H69 cells to neighboring (H69 or -DhuPGRN-H69 cells), naÝve cells
were co-cultured with EVs shed by liver fluke granulin-activated
DhuPGRN-H69. Extracellular vesicles were endocytosed by other cells,
as revealed by PKH-26 labelling [53], and delivered their cargo to the
recipient cells (Fig. 4A, B). Treatment with Pitstop 2 [40] blocked endo-
cytosis of EVs by H69 (Fig. 4C). H69 cell initiated endocytosis of EVs
within 30 min, and endocytosed 90% of cell population within
90 min (Fig. 4). CCA-related mRNAs in the cargo of EVs shed by liver
fluke granulin-activated DhuPGRN-H69 were functional and stimulated
changes in gene expression in naÝve recipient cholangiocytes. Focusing
on MAPK pathway phosphorylation from among these changes in gene
expression, we employed a commercial human MAPK phosphorylation
array that included 17 kinase phosphorylation sites (Fig. 4D). Following
co-culture with the (above) EVs, recipient cells were collected and pro-
cessed. The levels of seven proteins; GSK3a, MKK3, mTOR, p38, p53,
P70S6K and RSK1, were increased significantly in DhuPGRN-H69 cells
that had been treated with EVs from liver fluke granulin-activated
DhuPGRN-H69 compared with the control group (Fig. 4D–F) (2way
ANOVA, P = 0.0001). Duplicate assays were carried out, each using an
identical MAPK phosphorylation array membrane, where each membrane
itself included duplicate spots of each target protein in the pathway. The
pattern of protein induction was similar in EV-treated H69, except for
GSK3a (not significant) (Fig. 4D) (2way ANOVA, P = 0.0001). The indi-
rect amount of each protein was measured with normalized signal intensity
(RFU); more of these seven proteins were present in H69 than
DhuPGRN-H69 cells. For example, MKK3 showed 4000 RFU and
3700 RFU in the H69 and DhuPGRN-H69 control groups, respec-
tively. However, the activation of MAPK phosphorylation by mRNAs
from EVs shed by liver fluke granulin-activated DhuPGRN-H69 exhibited
a similar protein profile. These findings confirmed paracrine signaling
among cholangiocytes, which was accomplished by EV-mediated message
transfer from liver fluke granulin-exposed cells to naÝve cholangiocytes.Discussion
In East Asia, infection with fish-borne liver flukes is a major risk factor
for cholangiocarcinoma (CCA). The liver fluke O. viverrini secretes a
growth factor termed liver fluke granulin, Ov-GRN-1. This growth factor
is a paralogue of progranulin (PGRN), which is a secreted, cysteine-rich
glycoprotein that regulates cell division, survival, motility and migration.
Progranulin participates in embryonic development, wound repair, and
cancer. Mutations in the human progranulin gene, huPGRN, are associ-
ated with a spectrum on neurological disorders [54].
A paralogue from the liver fluke paralogue, liver fluke granulin, stimu-
lates cell proliferation, wound healing, and angiogenesis in vitro and con-
tributes to the pathogenesis of opisthorchiasis in vivo [17–22]. We have
exploited this link infection to explore the role of the secreted liver fluke
granulin in pre-malignant lesions by undertaking programmed CRISPR/
Cas9 knockout of the Ov-grn-1 gene from the genome of O. viverrini.
Infection with liver fluke granulin knockout worms results in markedly
reduced disease, which confirmed the key role for this liver fluke granulin
in hepatobiliary morbidity during opisthorchiasis [22].
Crosstalk between malignant and neighboring cells contributes to
tumor growth [55–58]. To investigate crosstalk among cholangiocytesrom ClinicalKey.com.au by Elsevier on March 26, 2021.
pyright ©2021. Elsevier Inc. All rights reserved.
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mRNAs from cultured cholangiocytes following exposure to liver fluke
granulin. To minimize the influence of endogenous progranulin,
huPGRN, the cognate gene, was inactivated using CRISPR/Cas9-based
gene knock-out. Cholangiocytes of the resulting mutant DhuPGRN-
H69 lines shown the proliferate rate as same as parental H69 cells
(Fig. 2C). Notably, however, cell growth recovered and increased follow-
ing exposure to liver fluke granulin.
Analysis using a CCA gene array indicated the cooperation of CCA
genes with the EVs following exposure to liver fluke granulin, in both
the H69 and DhuPGRN-H69 cells, highlighting the prominence of sig-
naling pathways in response to intracellular communication. The evRNA
expression pattern between H69 cells activated by exposure to liver fluke
granulin and, functioning together with human progranulin, induced
transcription of CCA-associated mRNAs (41 from 55 genes). By compar-
ison, the evRNA pattern from DhuPGRN-H69 (with only minimal levels
of progranulin) was substantially different (17 from 55 genes). This find-
ing supported a role for liver fluke granulin during opisthorchiasis-induced
carcinogenesis, involving activation of the MAPK pathway [17,59]. More-
over, functional MAPK evRNAs were transferred to naÝve cholangiocytes.
Endocytosis of EVs by the H69 and DhuPGRN-H69 recipient cells was
accomplished within 90 min. Subsequent in vivo translation of MAPK
evRNA from EVs shed from liver fluke granulin-activated DhuPGRN
H69 cells (pooled from 3 biological replicates) was confirmed for GSK3a,
MKK3, mTOR, p38, p53, p70S6K and RSK. In overview, EV-mediated
crosstalk in response to liver fluke granulin promoted CCA-specific pro-
grams including via MAPK signaling that, in turn, may contribute to
the CCA-conducive microenvironment.
Cholangiocytes express IL-6 and IL-8 through the TLR4-NF-kB and
MAPK signaling pathways [60]. The MAPK pathway is central to cholan-
giocarcinogenesis activated by Ov-GRN-1 during O. viverrini infection
[17,59]. For CCA development, oncogenic signaling pathways [61] partic-
ipate at many steps of carcinogenesis [62–64]. Wnt/b-catenin signaling
stimulates the pathobiology associated with CCA [65], with Wnt/b-
catenin signaling involved in the inflammation-associated CCA. Suppres-
sion of Wnt/b-catenin pathway signaling negatively impacts development
of CCA [65]. Apoptosis, growth, cellular intercommunication, and angio-
genesis of CCA cells related with receptor tyrosine kinase (RTK) signaling
that revealed the multiple kinases associated with PI3K/AKT, Wnt/b-
catenin, MAPK, and/or JAK/STAT signaling pathways [66–68]. Progran-
ulin affects the activation of the MAPK signaling pathway [69], high-
lighted by the upregulation of huPRGN activity during hepatocellular
carcinoma and as the gene target of microRNA-140-3p (miR-140-3p).
Overexpression of miR-140-3p disrupts the stimulation in the MAPK sig-
naling pathway by inhibition of expression of progranulin, leading to
phosphorylation of ERK and p38. Indeed, in this situation, c-Jun N-
terminal kinase is suppressed which, in turn, inhibits migration and inva-
sion by tumor cells [70].
Endogenous progranulin supplemented the action of liver fluke gran-
ulin in establishing a carcinogenesis-conducive transcriptional profile. This
outcome may mimic events during natural infection with the liver fluke
where the parasite residues within the bile duct, secreting liver fluke gran-
ulin which, in turn, is taken up by cholangiocytes [17] and which con-
tributes to biliary tract inflammation and fibrosis [6,21,52]. Here,
transcription levels of the MAPK13 and SOX2 were up regulated follow-
ing exposure of naÝve wild type or the DhuPGRN cells to EV-associated
RNAs from DhuPGRN-H69 cells that had been exposed to liver fluke
granulin. By contrast, SOX11 was up regulated in the wild type cells. Per-
turbation in the MAPK and Wnt signaling that is activated in these cells
may reflect the natural history of development of CCA [65] where SOX2
expression is upregulated in the precursor cell and supports self-renewal of
the transformed cell [71–73]. SOX11 plays a role in the tumor cellDownloaded for Anonymous User (n/a) at James Cook Univ
For personal use only. No other uses without permissprogression and in maintenance of the protein complex associated with
the Wnt and other signaling pathways that mediate angiogenesis [74–76].
This report has limitations. First, it is currently unclear how to inter-
pret the apparent inconsistency relating to the presence of ERBB2 but
not MAPK13 in EVs from both H69 and DhuPGRN-H69. However, this
might be tractable to investigation by transformation of cholangiocytes
with synthetic RNAs encoding these two genes and monitoring MAPK
phosphorylation and upregulation of the pathway members. Next, given
that this study was undertaken solely in vitro, follow-up studies in the ani-
mal models of human opisthorchiasis and infection-induced malignancy
should now be planned. Xenografts in immunosuppressed mice may be
informative particularly if the positive and negative controls include
human CCA cell lines as well as the parental wild type H69 cells are
included [77–79]. In addition, in further support of the hypothesis that
liver fluke granulin promotes extracellular vesicle-mediated crosstalk and
a cellular microenvironment conducive to CCA, future studies can incor-
porate three dimensional cell cultures, which have been described with
cholangiocytes [80] and/or cholangiocyte organoids [81,82]. Moreover,
studies with tumor registry samples from human cases of liver fluke
infection-associated cholangiocarcinoma can be designed to investigate
the presence and profiles of EVs and evRNAs from resected tumors
[83]. Last, since CCA displays heterogenous morphology and occurs at
different sites in the biliary tract [84,85], investigation of the interaction
of liver fluke granulin with discrete hepatic cell types such as hepatocytes
and hepatic stellate cells, in addition to cholangiocytes, can likely enhance
our understanding of opisthorchiasis-associated bile duct cancer.
Opisthorchiasis appears to induce global epigenetic deregulation in the
presence of chronic inflammation, provoked by the mechanical damage
inflicted by the feeding and by other activities of the parasite, including
secreted factors such as liver fluke granulin, thioredoxin peroxidase and, as
shown here, extracellular vesicles that modulate the gene expression profiles
[12,16,21,22]. Cholangiocarcinogenesis induced by chronic opisthorchiasis
and continuous exposure to liver fluke granulin may act through a RTK sig-
naling, perhaps signaling via ephrin pathway receptor [86], and the intercon-
nections of the MAPK and Wnt/b-catenin pathways. We established a line of
the H69 cholangiocyte with markedly diminished levels of endogenous pro-
granulin, using CRISPR/Cas9-mediated programmed gene knockout. The
findings presented here with the mutant H69 cell confirmed that EV-
mediated cellular communication, induced by exposure of cholangiocytes
to liver fluke granulin, modulated conserved signaling pathways in ways
reflective of cholangiocarcinogenesis.Acknowledgements
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